Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Ligand Pharmaceuticals Inc General Contingent Value Rt

US LGNYZ

NoneUSD
0.00(0%)

Last update at 2026-06-04T18:21:19.243115Z

Day Range

--
LowHigh

52 Week Range

0.00120.01
LowHigh

Fundamentals

  • Previous Close 0.05
  • Market Cap0.00000M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA30.94M
  • Revenue TTM153.60M
  • Revenue Per Share TTM8.95
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax 36.01M 47.30M -10.53800M 796.64M
Minority interest - - - -
Net income -5.21900M 37.46M -2.98500M 629.30M
Selling general administrative 70.06M 57.48M 64.44M -
Selling and marketing expenses - - - -
Gross profit 196.25M 214.96M 156.00M -5.72100M
Reconciled depreciation - - - -
Ebit 34.21M 47.35M 25.84M 832.38M
Ebitda 3.04M 98.42M 31.99M -
Depreciation and amortization -31.17500M 51.07M 6.14M -
Non operating income net other - - -8.96300M 25.31M
Operating income 34.21M 47.35M 25.84M 807.08M
Other operating expenses 193.21M 198.24M 208.11M 812.80M
Interest expense -1.79900M -19.62600M 27.42M 0.00000M
Tax provision - - - -
Interest income - - - -
Net interest income - - - -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 41.23M 9.84M 7.55M 167.34M
Total revenue 196.25M 277.13M 186.42M 120.28M
Total operating expenses 106.14M 136.06M 177.69M -812.79700M
Cost of revenue - 62.18M 30.42M 126.00M
Total other income expense net 1.80M -0.05400M -36.38300M -
Discontinued operations - - - -
Net income from continuing ops - - -2.98500M 629.30M
Net income applicable to common shares - - -2.98500M 629.30M
Preferred stock and other adjustments - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 762.67M 1297.59M 1362.29M 1494.91M
Intangible assets 342.45M 551.04M 595.33M 230.54M
Earning assets - - - -
Other current assets 8.01M 10.86M 6.04M 63.07M
Total liab 165.18M 476.43M 652.76M 727.68M
Total stockholder equity 597.49M 821.16M 709.52M 767.23M
Deferred long term liab - - 64.60M 32.94M
Other current liab 84.93M 16.06M 65.01M 4.75M
Common stock 0.02M 0.02M 0.02M 0.02M
Capital stock - - - -
Retained earnings 450.86M 449.09M 391.95M 400.11M
Other liab - - - -
Good will 105.67M 181.21M 189.66M 95.23M
Other assets - - - -
Cash 45.01M 19.52M 47.62M 71.54M
Cash and equivalents - - - -
Total current liabilities 98.81M 41.66M 100.11M 17.00M
Current deferred revenue 8.53M 11.00M 29.43M -
Net debt 42.74M 338.39M -45.73400M -
Short term debt 0.04M 6.21M 1.89M -
Short long term debt - - - -
Short long term debt total 87.75M 357.91M 1.89M -
Other stockholder equity 147.59M 372.97M 318.36M -0.21600M
Property plant equipment - - 14.43M 7.18M
Total current assets 263.60M 464.75M 500.56M 1123.64M
Long term investments - - - -
Net tangible assets - - -86.44600M 441.46M
Short term investments 166.86M 321.59M 363.57M 939.99M
Net receivables 30.42M 85.45M 56.85M 41.75M
Long term debt - - 442.29M 638.96M
Inventory 13.29M 27.33M 26.49M 7.30M
Accounts payable 5.31M 8.40M 3.78M 12.26M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income -0.98400M -0.91700M -0.80100M -
Additional paid in capital - - - -
Common stock total equity - - 0.02M 0.02M
Preferred stock total equity - - - -
Retained earnings total equity - - 391.95M 400.11M
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other 14.92M 29.06M 55.41M 12.71M
Deferred long term asset charges - - - -
Non current assets total 499.07M 832.84M 861.73M 25.61M
Capital lease obligations - - - -
Long term debt total - - 442.29M 638.96M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments - - 615.67M -326.81700M
Change to liabilities - - -4.58400M -4.39800M
Total cashflows from investing activities - - 231.65M 466.92M
Net borrowings - - -222.20900M -27.32300M
Total cash from financing activities -275.99000M -137.76100M -310.54500M -485.17200M
Change to operating activities - - - -
Net income -33.36100M 57.14M -2.98500M 629.30M
Change in cash 25.48M -28.44000M -24.31100M -47.59000M
Begin period cash flow 19.52M 47.96M - -
End period cash flow 25.48M 19.52M 47.96M -
Total cash from operating activities 137.85M 78.80M 54.59M -29.33600M
Issuance of capital stock - - - -
Depreciation 51.55M 51.07M 50.25M 38.08M
Other cashflows from investing activities - - -379.56500M 796.29M
Dividends paid - - - -
Change to inventory 12.06M -0.42700M -17.79900M -2.06100M
Change to account receivables 55.32M -28.61600M - -
Sale purchase of stock - - -74.98100M -450.43100M
Other cashflows from financing activities -275.93600M 18.00M -13.35500M -7.41800M
Change to netincome - - -1.82000M -717.86800M
Capital expenditures 17.92M 8.76M 4.46M 2.55M
Change receivables - - -26.06100M 25.46M
Cash flows other operating - - 57.59M 2.15M
Exchange rate changes - - - -
Cash and cash equivalents changes - - -24.31100M -47.59000M
Change in working capital 64.04M -59.57600M - -
Stock based compensation 60.28M 38.78M - -
Other non cash items -25.38400M - - -
Free cash flow 119.93M 70.04M - -

Peer Comparison

Sector: Industry:

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
LGNYZ
Ligand Pharmaceuticals Inc General Contingent Value Rt		 - -% - - - - -
DOGEF
Orsted A/S		 -1.046 4.02% 25.00 28.82 0.66 6.50 0.07 3.88 15.58
NCRRP
NCR Corp Pref A		 - -% 1002.00 1034.35 - - -
TBB
AT&T Inc. 5.35% GLB NTS 66		 - -% 20.76 4.60 - - -
CCZ
Comcast Holdings Corp		 0.21 0.32% 65.15 55.07 - - -

Reports Covered

Stock Research & News

View All

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.